ACell Expands MatriStem® Pelvic Floor Matrix Product Portfolio with Addition of Four Device Sizes - AZTV7/Cable 13, Me-TV 7.2, HSN 7.3, Phoenix-Prescott, AZ

ACell Expands MatriStem® Pelvic Floor Matrix Product Portfolio with Addition of Four Device Sizes

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ACell, Inc.

Offers broad range of regenerative therapy solutions

COLUMBIA, Md., Feb. 5, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has expanded the MatriStem® Pelvic Floor Matrix product portfolio with the addition of four device sizes. The addition of four new sizes to the portfolio offers a broad range of viable solutions for physicians treating patients in need of pelvic floor repair.

MatriStem Pelvic Floor Matrix is a naturally-occurring, non-synthetic scaffold that provides a unique balance of strength and pliability for use in repair of anterior, posterior and apical defects. Comprised of proprietary Urinary Bladder Matrix (UBM), MatriStem Pelvic Floor Matrix is intended for implantation to reinforce soft tissue where weakness exists in urological and gynecological anatomy including vaginal prolapse repair, reconstruction of pelvic floor, and pubourethral support.

On the market since 2010, MatriStem Pelvic Floor Matrix is currently available in 9x9x12cm (trapezoid) size, with four new sizes being added to the product line: 5x5cm, 4x12cm, 7x10cm and 10x15cm. The full line of products in five sizes was made available on January 10, 2014.

Rodney Bosley, President of ACell, remarked, "ACell has extended the MatriStem Pelvic Floor Matrix product portfolio with the addition of four sizes to provide a series of viable options for physicians treating patients requiring pelvic floor repair. We have seen a growing demand by physicians for devices that promote the formation of site-specific tissue and restore form through constructive remodeling. Our goal continues to be improving the lives of patients through offering effective tissue repair products."  

MatriStem products are medical devices that maintain and support a healing environment through constructive remodeling. Composed of naturally-occurring UBM, MatriStem maintains an intact epithelial basement membrane and facilitates the body's ability to form site specific tissue.

ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix (ECM) products to repair and remodel damaged tissues in a broad range of applications. Its patented MatriStem ECM medical devices maintain and support a healing environment through constructive remodeling and are available in particle and sheet forms for the treatment of acute wounds and various surgical procedures. For more information, visit www.acell.com.

About ACell, Inc.
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products. Its medical devices are cleared for a variety of indications and are marketed under the brand name "MatriStem." A privately held company, ACell produces MatriStem at its full scale manufacturing facilities in Columbia, MD and Lafayette, IN, and markets its products to physicians in the U.S. through a national direct sales force. For more information, call (800) 826-2926 or visit www.acell.com.

About MatriStem®
MatriStem products are porcine-derived extracellular matrix (ECM), essential structures that maintain and support a healing environment through constructive tissue remodeling. All MatriStem devices contain the basement membrane of porcine urinary bladder tissue, or urinary bladder matrix (UBM).  UBM is a layer of tissue that is a critical component of constructive tissue remodeling. It provides MatriStem products with several distinguishable characteristics, including the ability to facilitate the body's own regenerative capabilities and help restore normal site-appropriate tissue while avoiding scar tissue formation; the ability to be used "off-the-shelf" and stored at room temperature, with an approximate two year shelf life; and superior ease-of-use characteristics. MatriStem products are indicated for use in a wide range of regenerative and tissue repair applications and come in a range of sizes and thicknesses. It is the only ECM of its kind available in micronized particulate form. It has been cleared for use for the reinforcement of soft tissue where weakness exists in urological, gynecological and gastroenterological anatomy, which is referred to as surgical soft tissue repair, and for the management of wounds, such as pressure ulcers, venous ulcers, diabetic ulcers, second-degree burns, surgical wounds and trauma wounds, which is referred to as complex wound management. Refer to IFU supplied with each device for indications, contraindications, and precautions. All MatriStem devices are made in the USA. 

Contacts:

Nicole Bodine
Associate Product Manager
410-715-1700

Kirsten Thomas (media)
The Ruth Group
646-536-7014
kthomas@theruthgroup.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and AZ-TV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.